|
|
Clinical observation and effect of Salvia Tetramethylpyrazine Injection on serum homocysteine, high-sensitivity C-reactive protein and lipid levels in ischemic stroke |
CHEN Guoning LIN Zehui DU Yongming Li Quan |
Emergency Department, Chinese Medicine Hospital of Hainan Province, Guangzhou University of Chinese Medicine, Hainan Province, Haikou 570203, China |
|
|
Abstract Objective To explore the effect of Salvia Tetramethylpyrazine Injection on serum homocysteine, high-sensitivity C-reactive protein and lipid levels in ischemic stroke and clinical efficacy. Methods From February 2014 to November 2016, 100 patients with ischemic stroke in the emergency department of Chinese Medicine Hospital of Hainan Province, Guangzhou University of Chinese Medicine were selected and divided into treatment group and control group according to therapeutic schedule, with 50 cases in each group. The control group was treated with conventional treatment, while the treatment group was treated Salvia Tetramethylpyrazine Injection on the basis of control group. The serum homocysteine, high-sensitivity C-reactive protein, lipid levels, clinical efficacy, NIHSS score of the two groups were observed. Results After treatment, the levels of serum homocysteine, high-sensitivity C-reactive protein , total cholesterol, triacylglycerol and lipoprotein (a) in the treatment group were lower than those in the control group, with statistically significant difference ( P < 0.05). The NIHSS score and clinical efficacy of treatment group were significantly better than those of control group, with statistically significant difference (P < 0.05). Conclusion Salvia Tetramethylpyrazine Injection can reduce the serum homocysteine, high sensitivity c-reactive protein and serum lipid levels in patients with ischemic stroke, improve the clinical efficacy and neurological function.
|
|
|
|
|
[1] 吴江.神经病学[M].北京:人民卫生出版社,2005.
[2] 安泳潼,夏玉叶,闵旸.缺血性脑卒中的发病机制及其治疗[J].综述评论,2010,31(1):35-39.
[3] 刘俊田.动脉粥样硬化发病的炎症机制的研究进展[J].西南交通大学学报:医学版,2015,36(2):141-152.
[4] 李家邦.中医学[M].7版.北京:人民卫生出版社,2008.
[5] 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中国医学前沿杂志:电子版,2010,2:50-59.
[6] 郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002.
[7] 蔡业峰,贾真,张新春,等.美国国立卫生院卒中量表(NIHSS)中文版多中心测评研究——附537例缺血中风多中心多时点临床测评研究[J].北京中医药大学学报,2008,31(7):494-498.
[8] 王文志.中国脑卒中流行病学特征和社区人群干预[J].中国医学前沿杂志:电子版,2009,1(2):49-53.
[9] Nordestgaard BG,Chapman MJ,Ray K,et al. Lipoprotein(a)as a cardiovascular risk factor:current status [J]. Eur Heart J,2010,31(23):2844-2853.
[10] Umahara T,Uchihara T,Yamada S,et al. Differential expression of oxidized/native lipoprotein(a)and plasminogen in human carotid and cerebral artery plaques [J]. Atherosclerosis,2011,215(2):392-398.
[11] Jacob J,Joseph L. Methoxistasis:integrating the roles of homocysteine and folic acid in cardiovascular pathobiology [J]. Nutrients,2013,5(8):3235-3256
[12] Schalinske KL,Smazal AL. Homocysteine imbalance:a pathological metabolic marker [J]. Adv Nutr,2012,3(6):755-762.
[13] Song S,Kertowidjojo E,Ojaimi C,et al. Longterm methionine-diet induced mild heperhomocysteinemia associated cardiac metabolic dysfunction in multiarous rats [J]. Physiol Rep,2015,3(5):e12 292.
[14] Jia SJ,Lai YQ,Zhao M,et al. Homocysteine-induced hypermethylation of DDAH2 promoter contributes to apoptosis of endothelial cells [J]. Pharmazie,2013,68(3):282-286.
[15] Boysen G,Brander T,Christensen H,et al. Homocysteine and risk of recurrent stroke [J]. Stroke,2003,34(5):1258-1261.
[16] 王晶,刘家丰,郭兆慧,等.高同型半胱氨酸血症与老年急性脑梗死预后的关系研究[J].中华高血压杂志,2013, 15(11):599-601.
[17] 童海,涂玉林.高敏C反应蛋白与动脉粥样硬化[J].中国动脉硬化杂志,2010,18(9):746-750.
[18] Vilahur G,Hernndez-Vera R,Molins B,et al. Short-term myocardial ischemia induces cardiac modified C-reactive protein expression and proinflammatory gene (cyclo-oxygenase-2,monocyte chemoattractant protein-1,and tissue factor)upregulation in peripheral blood mononuclear cells [J]. J Thromb Haemost,2009,7(3):485-493.
[19] Lavallée PC,Labreuche J,Faille D,et al. Circulating markers of endothelial dysfunction and platelet activation in patients with severe symptomatic cerebral small vessel disease [J]. Cerebrovasc Dis,2013,36(2):131-138.
[20] Di Napoli M,Papa F,Bocola V,et al. Prognostic inf luence of increased C-reactive protein and fibrinogen levels in ischemic stroke [J]. Stroke,2001,32(1):133-138.
[21] 吴兴利,高玉玲,李金珉,等.丹参多酚酸盐对氧化低密度脂蛋白促血管平滑肌细胞分泌作用的影响[J].东南大学学报:医学版,2010,29(2):169-172.
[22] 何文凤,吕湛,张全波.丹参酮在心血管保护中的药理作用机制研究进展[J].中国医药导报,2013,10(29):34-38.
[23] 王世龙,林原,唐泽耀.川芎嗪在各类神经系统损伤中的保护作用及其机制研究进展[J].中国药理学通报,2010,26(4):438-440. |
|
|
|